Abstract
The 17 enzyme–modifier interaction mechanisms identified by taxonomic criteria are by no means only theoretical concepts. They are all represented in thousands of reports, though their real identity may not be recognized at a glance. One factor is inconsistent nomenclature and another is collecting mechanisms in pools of undifferentiated special cases. Representative examples that span several branches of the biological sciences are discussed in this chapter for the 17 basic mechanisms highlighting the methods used by the authors in data interpretation. Substrates and reaction products in the role of modifiers are discussed within the mechanisms to which they belong.
The vast majority of textbooks (even the most recent ones) continue the ‘romance’ with the double-reciprocal plot, in spite of the severe way it is affected by experimental errors.
Adams KAH, Storer AC, Cornish-Bowden A (1984). J Chem Educ 61:527
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsNotes
- 1.
[(2R,4R,5S)-2-Benzyl-5-(Boc-amino)-4-hydroxy-6-phenyl-hexanoyl]-Leu-Phe-NH2.
- 2.
A microsomal cytochrome P-450-dependent activity.
- 3.
This is EC 1.6.5.9, whereas the proton-translocating enzyme is EC 1.6.5.3.
- 4.
Reported as \(\mathrm{Q} \approx 3\) and \(\mathrm{W} \approx 0.1\).
- 5.
As an aid to locate the unnumbered rate equation, this is in the middle of p. 193, the case for which ϕ s = ϕ a.
- 6.
The reluctance in accepting rules and recommendations released by International Organizations in the interest of the scientific community does not help the dissemination of scientific information using a common language.
References
Abou El-Magd RM, Park HK, Kawazoe T, Iwana S, Ono K, Chung SP, Miyano M, Yorita K, Sakai T, Fukui K (2010) The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia. J Psychopharmacol 24:1055–1067. doi:10.1177/0269881109102644
Almond A, Sheehan JK (2000) Glycosaminoglycan conformation: do aqueous molecular dynamics simulations agree with x-ray fiber diffraction? Glycobiology 10:329–338. doi:10.1093/glycob/10.3.329
Amstutz P, Binz HK, Parizek P, Stumpp MT, Kohl A, Grütter MG, Forrer P, Plückthun A (2005) Intracellular kinase inhibitors selected from combinatorial libraries of designed ankyrin repeat proteins. J Biol Chem 280:24715–24722
Atkinson SC, Dogovski C, Downton MT, Czabotar PE, Dobson RCJ, Gerrard JA, Wagner J, Perugini MA (2013) Structural, kinetic and computational investigation of Vitis vinifera DHDPS reveals new insight into the mechanism of lysine-mediated allosteric inhibition. Plant Mol Biol 81:431–446. doi:10.1007/s11103-013-0014-7
Baici A (2002) Myeloblastin. In: Kazazian HH (ed) Wiley encyclopedia of molecular medicine, vol 3. Wiley, New York, pp 2181–2183
Baici A, Bradamante P (1984) Interaction between human leukocyte elastase and chondroitin sulfate. Chem-Biol Interact 51:1–11
Baici A, Diczházi C, Neszmélyi A, Móczár E, Hornebeck W (1993) Inhibition of the human leukocyte endopeptidases elastase and cathepsin G and of porcine pancreatic elastase by N-oleoyl derivatives of heparin. Biochem Pharmacol 46:1545–1549. doi:10.1016/0006-2952(93)90321-M
Baici A, Szedlacsek SE, Früh H, Michel BA (1996) pH-dependent hysteretic behaviour of human myeloblastin (leucocyte proteinase 3). Biochem J 317:901–905
Baici A, Schenker P, Wächter M, Rüedi P (2009) 3-Fluoro-2,4-dioxa-3-phosphadecalins as inhibitors of acetylcholinesterase. A reappraisal of kinetic mechanisms and diagnostic methods. Chem Biodivers 6:261–282
Barr JT, Jones JP (2011) Inhibition of human liver aldehyde oxidase: implications for potential drug-drug interactions. Drug Metab Disp 39:2381–2386. doi:10.1124/dmd.111.041806
Berman HA, Leonard K (1990) Ligand exclusion on acetylcholinesterase. Biochemistry 29:10640–10649. doi:10.1021/bi00499a010
Bezerra RM, Dias AA, Fraga I, Pereira AN (2011) Cellulose hydrolysis by cellobiohydrolase Cel7A shows mixed hyperbolic product inhibition. Appl Biochem Biotechnol 165:178–189. doi:10.1007/s12010-011-9242-y
Bincoletto C, Tersariol ILS, Oliveira CR, Dreher S, Fausto DM, Soufen MA, Nascimento FD, Caires ACF (2005) Chiral cyclopalladated complexes derived from N,N-dimethyl-1-phenethylamine with bridging bis(diphenylphosphine)ferrocene ligand as inhibitors of the cathepsin B activity and as antitumoral agents. Bioorg Med Chem 13:3047–3055. doi:10.1016/j.bmc.2005.01.057
Binz HK, Stumpp MT, Forrer P, Amstutz P, Plückthun A (2003) Designing repeat proteins: well-expressed, soluble and stable proteins from combinatorial libraries of consensus ankyrin repeat proteins. J Mol Biol 332:489–503
Binz HK, Amstutz P, Kohl A, Stumpp MT, Briand C, Forrer P, Grütter MG, Plückthun A (2004) High-affinity binders selected from designed ankyrin repeat protein libraries. Nat Biotechnol 22:575–582
Brandt M, Greway AT, Holt DA, Metcalf BW, Levy MA (1990) Studies on the mechanism of steroid 5-a-reductase inhibition by 3-carboxy A-ring aryl steroids. J Steroid Biochem Mol Biol 37:575–579. doi:10.1016/0960-0760(90)90403-8
Cadène M, Duranton J, North A, Sitahar M, Chignard M, Bieth JG (1997) Inhibition of neutrophil serine proteinases by suramin. J Biol Chem 272:9950–9955
Casu B, Petitou M, Provasoli M, Sinaÿ P (1988) Conformational flexibility: a new concept for explaining binding and biological properties of iduronic acid-containing glycosaminoglycans. Trends Biochem Sci 13:221–225
Cornish-Bowden A (1986) Why is uncompetitive inhibition so rare? A possible explanation, with implications for the design of drugs and pesticides. FEBS Lett 203:3–6. doi:10.1016/0014-5793(86)81424-7
Cornish-Bowden A (1998) Two centuries of catalysis. J Biosci 23:87–92
Cornish-Bowden A (2012) Fundamentals of enzyme kinetics, 4th edn. Wiley, Weinheim
DiMaio J, Gibbs B, Munn D, Lefebvre J, Ni F, Konishi Y (1990) Bifunctional thrombin inhibitors based on the sequence of hirudin45-65. J Biol Chem 265:21698–21703
Dixon M, Webb EC (1979) Enzymes, 3rd edn. Longman, London
Dobson RCJ, Griffin MDW, Roberts SJ, Gerrard JA (2004) Dihydrodipicolinate synthase (DHDPS) from Escherichia coli displays partial mixed inhibition with respect to its first substrate, pyruvate. Biochimie 86:311–315. doi:10.1016/j.biochi.2004.03.008
Doehlert DC, Huber SC (1983) Spinach leaf sucrose phosphate synthase: activation by glucose 6-phosphate and interaction with inorganic phosphate. FEBS Lett 153:293–297. doi:10.1016/0014-5793(83)80627-9
Doehlert DC, Huber SC (1984) Phosphate inhibition of spinach leaf sucrose phosphate synthase as affected by glucose-6-phosphate and phosphoglucoisomerase. Plant Physiol 76:250–253
Domagk G (1935) Ein Beitrag zur Chemotherapie der bakteriellen Infektionen. Deut Med Wochenschr 61:250–253
Drainas D, Kalpaxis DL, Coutsogeorgopoulos C (1987) Inhibition of ribosomal peptidyltransferase by chloramphenicol. Kinetic studies. Eur J Biochem 164:53–58
Eisenthal R, Cornish-Bowden A (1974) The direct linear plot. A new graphical procedure for estimating enzyme kinetic parameters. Biochem J 139:715–720
Feldman T, Kabaleeswaran V, Jang SB, Antczak C, Djaballah H, Wu H, Jiang X (2012) A class of allosteric caspase inhibitors identified by high-throughput screening. Mol Cell 47:585–595. doi:10.1016/j.molcel.2012.06.007
Fischer RS, Rubin JL, Gaines CG, Jensen RA (1987) Glyphosate sensitivity of 5-enol-pyruvylshikimate-3-phosphate synthase from Bacillus subtilis depends upon state of activation induced by monovalent cations. Arch Biochem Biophys 256:325–334
Forrer P, Stumpp MT, Binz HK, Plückthun A (2003) A novel strategy to design binding molecules harnessing the modular nature of repeat proteins. FEBS Lett 539:2–6
Francis PT, Palmer AM, Snape M, Wilcock GK (1999) The cholinergic hypothesis of Alzheimer’s disease: a review of progress. J Neurol Neurosurg Psychiatry 66:137–147. doi:10.1136/jnnp.66.2.137
Franzke CW, Baici A, Bartels J, Christophers E, Wiedow O (1996) Antileukoprotease inhibits stratum corneum chymotryptic enzyme. Evidence for a regulative function in desquamation. J Biol Chem 271:21,886–21,890
Frieden C (1963) Glutamate dehydrogenase. V. The relation of enzyme structure to the catalytic function. J Biol Chem 238:3286–3299
Früh H, Kostoulas G, Michel BA, Baici A (1996) Human myeloblastin (leukocyte proteinase 3): Reactions with substrates, inactivators and activators in comparison with leukocyte elastase. Biol Chem 377:579–586
Gao WQ, Anderson PJ, Majerus EM, Tuley EA, Sadler JE (2006) Exosite interactions contribute to tension-induced cleavage of von Willebrand factor by the antithrombotic ADAMTS13 metalloprotease. Proc Natl Acad Sci USA 103:19099–19104
González-Tanarro CM, Gütschow M (2011) Hyperbolic mixed-type inhibition of acetylcholinesterase by tetracyclic thienopyrimidines. J Enzyme Inhib Med Chem 26:350–358. doi:10.3109/14756366.2010.504674
Gupta S, Mahmood S, Mahmood A (2009) Kinetic characteristics of brush border sucrase activation by Na+ ions in mice intestine. Indian J Exp Biol 47:811–815
Hallcher LM, Sherman WR (1980) The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J Biol Chem 255:10896–10901
Hedstrom L (2009) IMP dehydrogenase: structure, mechanism, and inhibition. Chem Rev 109:2903–2928. doi:10.1021/cr900021w
Heng S, Tieu W, Hautmann S, Kuan K, Pedersen DS, Pietsch M, Gütschow M, Abell AD (2011) New cholesterol esterase inhibitors based on rhodanine and thiazolidinedione scaffolds. Bioorg Med Chem 19:7453–7463. doi:10.1016/j.bmc.2011.10.042
Hongsawat P, Vangnai AS (2011) Biodegradation pathways of chloroanilines by Acinetobacter baylyi strain GFJ2. J Hazard Mater 186:1300–1307. doi:10.1016/j.jhazmat.2010.12.002
Inagami T (1964) The mechanism of the specificity of trypsin catalysis. I. Inhibition by alkyl ammonium ions. J Biol Chem 239:787–791
Inagami T, Murachi T (1964) The mechanism of the specificity of trypsin catalysis. III. Activation of the catalytic site of trypsin by alkylammonium ions in the hydrolysis of acetylglycine ethyl ester. J Biol Chem 239:1395–1401
Inagami T, York SS (1968) Effect of alkyl guanidines and alkyl amines on trypsin catalysis. Biochemistry 7:4045–4052. doi:10.1021/bi00851a036
Joshi N, Hoobler EK, Perry S, Diaz G, Fox B, Holman TR (2013) Kinetic and structural investigations into the allosteric and pH effect on the substrate specificity of human epithelial 15-lipoxygenase-2. Biochemistry 52:8026–8035. doi:10.1021/bi4010649
Kazan D, Erarslan A (1997) Stabilization of Escherichia coli penicillin G acylase by polyethylene glycols against thermal inactivation. Appl Biochem Biotechnol 62:1–13
Kim Y, Arp DJ, Semprini L (2002) Kinetic and inhibition studies for the aerobic cometabolism of 1,1,1-trichloroethane, 1,1-dichloroethylene, and 1,1-dichloroethane by a butane-grown mixed culture. Biotechnol Bioeng 80:498–508
King JB, West MB, Cook PF, Hanigan MH (2009) A novel, species-specific class of uncompetitive inhibitors of g-glutamyl transpeptidase. J Biol Chem 284:9059–9065
Kohl A, Binz HK, Forrer P, Stumpp MT, Plückthun A, Grütter MG (2003) Designed to be stable: crystal structure of a consensus ankyrin repeat protein. Proc Natl Acad Sci USA 100:1700–1705
Kostoulas G, Hörler D, Naggi A, Casu B, Baici A (1997) Electrostatic interactions between human leukocyte elastase and sulfated glycosaminoglycans: physiological implications. Biol Chem 378:1481–1489
Kovačič L, Novinec M, Petan T, Baici A, Križaj I (2009) Calmodulin is a nonessential activator of secretory phospholipase A(2). Biochemistry 48:11,319–11,328
Küçükkilinç TT, Ozer I (2008) Inhibition of electric eel acetylcholinesterase by triarylmethane dyes. Chem-Biol Interact 175:309–311. doi:10.1016/j.cbi.2008.05.008
Ledoux D, Papy-Garcia D, Escartin Q, Sagot MA, Cao Y, Barritault D, Courtois J, Hornebeck W, Caruelle JP (2000) Human plasmin enzymatic activity is inhibited by chemically modified dextrans. J Biol Chem 275:29383–29390. doi:10.1074/jbc.M000837200
Leech AP, Baker GR, Shute JK, Cohen MA, Gani D (1993) Chemical and kinetic mechanism of the inositol monophosphatase reaction and its inhibition by Li+. Eur J Biochem 212:693–704
Li Z, Kienetz M, Cherney MM, James MN, Brömme D (2008) The crystal and molecular structures of a cathepsin K:chondroitin sulfate complex. J Mol Biol 383:78–91. doi:S0022-2836(08)00880-2 [pii] 10.1016/j.jmb.2008.07.038
Lorey S, Stöckel-Maschek A, Faust J, Brandt W, Stiebitz B, Gorrell MD, Kähne T, Mrestani-Klaus C, Wrenger S, Reinhold D, Ansorge S, Neubert K (2003) Different modes of dipeptidyl peptidase IV (CD26) inhibition by oligopeptides derived from the N-terminus of HIV-1 Tat indicate at least two inhibitor binding sites. Eur J Biochem 270:2147–2156
Lüönd RM, McKie JH, Douglas KT, Dascombe MJ, Vale J (1998) Inhibitors of glutathione reductase as potential antimalarial drugs. Kinetic cooperativity and effect of dimethyl sulphoxide on inhibition kinetics. J Enzyme Inhib 13:327–345
Madsen JL, Andersen TL, Santamaria S, Nagase H, Enghild JJ, Skrydstrup T (2012) Synthesis and evaluation of silanediols as highly selective uncompetitive inhibitors of human neutrophil elastase. J Med Chem 55:7900–7908. doi:10.1021/jm301000k
Martinek K, Varfolomeev SD, Levashov AV, Berezin IV (1971) Kinetic manifestations of the structure of the active center of a-chymotrypsin on interacting with fragments of specific substrates. Mol Biol Engl Transl 5:278–286
Masson P, Froment MT, Gillon E, Nachon F, Lockridge O, Schopfer LM (2008) Kinetic analysis of effector modulation of butyrylcholinesterase-catalysed hydrolysis of acetanilides and homologous esters. FEBS J 275:2617–2631. doi:10.1111/j.1742-4658.2008.06409.x
Michaelis L, Pechstein H (1914) Über die verschiedenartige Natur der Hemmungen der Invertasewirkung. Biochem Z 60:79–90
Michaelis L, Rona P (1914) Die Wirkungsbedingungen der Maltase aus Bierhefe. III. Über die Natur der verschiedenenartigen Hemmungen der Fermentwirkungen. Biochem Z 60:62–78
Mogul R, Johansen E, Holman TR (2000) Oleyl sulfate reveals allosteric inhibition of soybean lipoxygenase-1 and human 15-lipoxygenase. Biochemistry 39:4801–4807
Monod J, Changeux JP, Jacob F (1963) Allosteric proteins and cellular control systems. J Mol Biol 6:306–329
Monod J, Wyman J, Changeux JP (1965) On the nature of allosteric transitions: a plausible model. J Mol Biol 12:88–118
Murray M, Farrell GC (1986) Mechanistic aspects of the inhibition of microsomal drug oxidation by primaquine. Biochem Pharmacol 35:2149–2155
Nakanishi M, Moriyama A, Narita Y, Sasaki M (1989) Aminopeptidase-M from human liver. II. Kinetic analysis of inhibition of the enzyme by bile acids. J Biochem 106:826–830
Nomenclature Committee of the International Union of Biochemistry (1982) Symbolism and terminology in enzyme kinetics. Recommendations 1981. Eur J Biochem 128:281–291
Novinec M, Kovačič L, Lenarčič B, Baici A (2010) Conformational flexibility and allosteric regulation of cathepsin K. Biochem J 429:379–389. doi:10.1042/BJ20100337
Novinec M, Korenč M, Caflisch A, Ranganathan R, Lenarčič B, Baici A (2014) A novel allosteric mechanism in the cysteine peptidase cathepsin K discovered by computational methods. Nat Commun 5:3287. doi:10.1038/ncomms4287
Novinec M, Lenarčič B, Baici A (2014) Probing the activity modification space of the cysteine peptidase cathepsin K with novel allosteric modifiers. PLoS One 9:e106642. doi:10.1371/journal.pone.0106642
Orsi BA, McFerran N, Hill A, Bingham A (1972) Kinetics and the mechanism of action of adenosine aminohydrolase. Biochemistry 11:3386–3392
Park YD, Kim SY, Lyou YJ, Lee JY, Yang JM (2005) A new type of uncompetitive inhibition of tyrosinase induced by Cl- binding. Biochimie 87:931–937. doi:10.1016/j.biochi.2005.06.006
Pawlyk AC, Pettigrew DW (2002) Transplanting allosteric control of enzyme activity by protein-protein interactions: Coupling a regulatory site to the conserved catalytic core. Proc Natl Acad Sci USA 99:11115–11120. doi:10.1073/pnas.132393599
Pettigrew DW (2009) Amino acid substitutions in the sugar kinase/hsp70/actin superfamily conserved ATPase core of E. coli glycerol kinase modulate allosteric ligand affinity but do not alter allosteric coupling. Arch Biochem Biophys 481:151–156. doi:10.1016/j.abb.2008.11.020
Phillips MF, Mantle TJ (1991) The initial-rate kinetics of mouse glutathione S-transferase YfYf. Evidence for an allosteric site for ethacrynic acid. Biochem J 275:703–709
Raina A, Hyvönen T, Eloranta T, Voutilainen M, Samejima K, Yamanoha B (1984) Polyamine synthesis in mammalian tissues. Isolation and characterization of spermidine synthase from bovine brain. Biochem J 219:991–1000
Rothe M, Zichner A, Auerswald EA, Dodt J (1994) Structure/function implications for the aminopeptidase specificity of aleurain. Eur J Biochem 224:559–565. doi:10.1111/j.1432-1033.1994.00559.x
Ruddat VC, Whitman S, Holman TR, Bernasconi CF (2003) Stopped-flow kinetic investigations of the activation of soybean lipoxygenase-1 and the influence of inhibitors on the allosteric site. Biochemistry 42:4172–4178. doi:10.1021/bi020698o
Schechter I, Berger A (1967) On the size of the active sites in proteases. I. Papain. Biochem Biophys Res Commun 27:157–162
Schenker P, Alfarano P, Kolb P, Caflisch A, Baici A (2008) A double-headed cathepsin B inhibitor devoid of warhead. Protein Sci 17:2145–2155
Schiroli D, Ronda L, Peracchi A (2015) Kinetic characterization of the human O-phosphoethanolamine phospho-lyase reveals unconventional features of this specialized pyridoxal phosphate-dependent lyase. FEBS J 282:183–199. doi:10.1111/febs.13122
Schmitz T, Rothe M, Dodt J (1991) Mechanism of the inhibition of a-thrombin by hirudin-derived fragments hirudin(1–47) and hirudin(45–65). Eur J Biochem 195:251–256
Schulte M, Mattay D, Kriegel S, Hellwig P, Friedrich T (2014) Inhibition of Escherichia coli respiratory complex I by Zn2+. Biochemistry 53:6332–6339. doi:10.1021/bi5009276
Schweizer A, Roschitzki-Voser H, Amstutz P, Briand C, Gulotti-Georgieva M, Prenosil E, Binz HK, Capitani G, Baici A, Plückthun A, Grütter MG (2007) Inhibition of caspase-2 by a designed ankyrin repeat protein: specificity, structure, and inhibition mechanism. Structure 15:625–636. doi:10.1016/j.str.2007.03.014
Segal HL, Kachmar JF, Boyer PD (1952) Kinetic analysis of enzyme reactions. I. Further considerations of enzyme inhibition and analysis of enzyme activation. Enzymologia 15:187–198
Segel IH (1975) Enzyme kinetics. Behavior and analysis of rapid equilibrium and steady-state enzyme systems. Wiley, New York
Semenza G (1969) A kinetic investigation on the allosteric effects in intestinal sucrase. Eur J Biochem 8:518–529. doi:10.1111/j.1432-1033.1969.tb00557.x
Sheehan JP, Phan TM (2001) Phosphorothioate oligonucleotides inhibit the intrinsic tenase complex by an allosteric mechanism. Biochemistry 40:4980–4989
Shikita M, Fahey JW, Golden TR, Holtzclaw WD, Talalay P (1999) An unusual case of ‘uncompetitive activation’ by ascorbic acid: purification and kinetic properties of a myrosinase from Raphanus sativus seedlings. Biochem J 341:725–732
Siemann S, Evanoff DP, Marrone L, Clarke AJ, Viswanatha T, Dmitrienko GI (2002) N-arylsulfonyl hydrazones as inhibitors of IMP-1 metallo-beta-lactamase. Antimicrob Agents Chemother 46:2450–2457
Snášel J, Nauš P, Dostál J, Hnízda A, Fanfrlík J, Brynda J, Bourderioux A, Dušek M, Dvoráková H, Stolaríková J, Zábranská H, Pohl R, Konečný P, Džubák P, Votruba I, Hajdúch M, Rezáčová P, Veverka V, Hocek M, Pichová I (2014) Structural basis for inhibition of mycobacterial and human adenosine kinase by 7-substituted 7-(Het)aryl-7-deazaadenine ribonucleosides. J Med Chem 57:8268–8279. doi:10.1021/jm500497v
Sohier JS, Laurent C, Chevigné A, Pardon E, Srinivasan V, Wernery U, Lassaux P, Steyaert J, Galleni M (2013) Allosteric inhibition of VIM metallo-beta-lactamases by a camelid nanobody. Biochem J 450:477–486. doi:10.1042/bj20121305
Srinivasan B, Forouhar F, Shukla A, Sampangi C, Kulkarni S, Abashidze M, Seetharaman J, Lew S, Mao L, Acton TB, Xiao R, Everett JK, Montelione GT, Tong L, Balaram H (2014) Allosteric regulation and substrate activation in cytosolic nucleotidase II from Legionella pneumophila. FEBS J 281:1613–1628. doi:10.1111/febs.12727
Sternson LA, Gammans RE (1976) Effect of aromatic nitro compounds on oxidative metabolism by cytochrome P-450 dependent enzymes. J Med Chem 19:174–177
Sun W, Wendt M, Klebe G, Röhm KH (2014) On the interpretation of tyrosinase inhibition kinetics. J Enzyme Inhib Med Chem 29:92–99. doi:10.3109/14756366.2012.755621
Szewczuk Z, Gibbs BF, Yue SY, Purisima E, Zdanov A, Cygler M, Konishi Y (1993) Design of a linker for trivalent thrombin inhibitors: interaction of the main chain of the linker with thrombin. Biochemistry 32:3396–3404
Takimoto K, Okada M, Matsuda Y, Nakagawa H (1985) Purification and properties of myo-inositol-1-phosphatase from rat brain. J Biochem (Tokyo) 98:363–370
Tian GC, Sobotka-Briner CD, Zysk J, Liu XD, Birr C, Sylvester MA, Edwards PD, Scott CD, Greenberg BD (2002) Linear non-competitive inhibition of solubilized human gamma-secretase by pepstatin a methylester, L685458, sulfonamides, and benzodiazepines. J Biol Chem 277:31499–31505
Tipton KF (1996) Patterns of enzyme inhibition. In: Engel PC (ed) Enzymology LabFax. Academic Press Inc., San Diego, pp 115–174
Velazquez I, Pardo JP (2001) Kinetic characterization of the rotenone-insensitive internal NADH: ubiquinone oxidoreductase of mitochondria from Saccharomyces cerevisiae. Arch Biochem Biophys 389:7–14. doi:10.1006/abbi.2001.2293
Wang W, Hedstrom L (1997) Kinetic mechanism of human inosine 5’-monophosphate dehydrogenase type II: random addition of substrates and ordered release of products. Biochemistry 36:8479–8483. doi:10.1021/bi970226n
Westley AM, Westley J (1996) Enzyme inhibition in open systems. Superiority of uncompetitive agents. J Biol Chem 271:5347–5352
White PW, Faucher AM, Massariol MJ, Welchner E, Rancourt J, Cartier M, Archambault J (2005) Biphenylsulfonacetic acid inhibitors of the human papillomavirus type 6 E1 helicase inhibit ATP hydrolysis by an allosteric mechanism involving tyrosine 486. Antimicrobial agents and chemotherapy 49:4834–4842. doi:10.1128/AAC.49.12.4834-4842.2005
Wickham S, Regan N, West MB, Thai J, Cook PF, Terzyan SS, Li PK, Hanigan MH (2013) Inhibition of human gamma-glutamyl transpeptidase: development of more potent, physiologically relevant, uncompetitive inhibitors. Biochem J 450:547–557. doi:10.1042/bj20121435
Woods DD (1940) The relation of p-aminobenzoic acid to the mechanism of the action of sulphanilamide. Brit J Exp Pathol 21:74–90
Woods MJ, Findlater JD, Orsi BA (1979) Kinetic mechanism of the aliphatic amidase from Pseudomonas aeruginosa. Biochim Biophys Acta 567:225–237
Worcel A, Goldman DS (1964) Activation by AMP of the NADH oxidase of Mycobacterium tuberculosis. Biochem Biophys Res Commun 17:559–564
Worcel A, Goldman DS, Cleland WW (1965) An allosteric reduced nicotinamide adenine dinucleotide oxidase from Mycobacterium tuberculosis. J Biol Chem 240:3399–3407
Xiao ZP, Peng ZY, Dong JJ, Deng RC, Wang XD, Ouyang H, Yang P, He J, Wang YF, Zhu M, Peng XC, Peng WX, Zhu HL (2013) Synthesis, molecular docking and kinetic properties of beta-hydroxy-beta-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors. Eur J Med Chem 68:212–221. doi:10.1016/j.ejmech.2013.07.047
Yoshino M (1987) A graphical method for determining inhibition parameters for partial and complete inhibitors. Biochem J 248:815–820
Zhang Y, Ribeiro JMC, Guimarães JA, Walsh PN (1998) Nitrophorin-2, a novel mixed-type reversible specific inhibitor of the intrinsic factor-X activating complex. Biochemistry 37:10681–10690. doi:10.1021/bi973050y
Author information
Authors and Affiliations
Appendix
Appendix
5.1.1 Rate Equations for Linear Specific Inhibition and Linear Specific Activation
In linear specific inhibition, the association between enzyme and inhibitor (X) is in equilibrium because EX is a dead-end complex . Therefore, using the Cha simplification of the King–Altman method for paths in equilibrium, this step can be represented as node (A), while the second node (B) is constituted by the single species ES as shown in Scheme 5.9a.
In deriving the rate equation for essential activation the association of E and X is also considered to be in rapid equilibrium. This assumption is partly justified by the fact that essential activators are often either rapidly reacting protons or small ions. The values of the nodes are as shown in Scheme 5.9b. The numbering of constants for linear specific activation is maintained coherent with the topology of the general modifier mechanism.
Values of the nodes:
Fractions of species in the nodes:
Values of the nodes corrected for fractions of the species within the nodes:
Fractions of nodes B, needed for calculating the velocity; the fractions in nodes A are not needed for this purpose:
Rate equations:
The rate equations for LSpI and LSpA differ for the term in the denominator that multiplies the Michaelis constant, i.e., \(1 + \left [\mathrm{X}\right ]\left /\right. K_{\mathrm{Sp}}\) and \(1 + K_{\mathrm{Sp}}\left /\right. \left [\mathrm{X}\right ]\), respectively. Thus the apparent Michaelis constant of LSpI depends linearly on \(\left [\mathrm{X}\right ]\), while it is linear with \(1\left /\right. \left [\mathrm{X}\right ]\) in LSpA.
5.1.2 Rate Equation for Linear Catalytic Inhibition
In linear catalytic inhibition, ESX is a dead-end complex that operates at equilibrium when the system is in steady-state (Scheme 5.10). Using the reasoning above for linear specific inhibition and activation, the steps to obtain the rate equation are shown below without comments.
Rights and permissions
Copyright information
© 2015 Springer-Verlag Wien
About this chapter
Cite this chapter
Baici, A. (2015). The Basic Mechanisms of Inhibition and Nonessential Activation. In: Kinetics of Enzyme-Modifier Interactions. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1402-5_5
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1402-5_5
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-1401-8
Online ISBN: 978-3-7091-1402-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)